Advanced chromatography solutions for high-performance biotherapeutics separations. Sepax Technologies, Inc. is a Delaware-based chromatography company focused on solving complex challenges in biologics analysis and purification. We design and manufacture high-performance HPLC columns and process media that support bioanalytical characterization, downstream processing, and purification across a wide range of modalities, including mAbs, bispecific antibodies, ADCs, recombinant proteins, AAVs, VLPs, and nucleic acids. Our innovation is built on deep expertise in polymer bead engineering, linker and organic synthesis, and protein chemistry. This integrated foundation enables consistent, high-resolution performance from early-stage R&D through commercial manufacturing. At Sepax, we focus on what matters most in real workflows: reproducibility, resolution, and methods that hold up under real-world conditions.
Looking for a particular Sepax Technologies, Inc. employee's phone or email?
The Sepax Technologies, Inc. annual revenue was $15.2 million in 2026.
Xueying Huang is the President of Sepax Technologies, Inc..
67 people are employed at Sepax Technologies, Inc..
Sepax Technologies, Inc. is based in Newark, Delaware.
The NAICS codes for Sepax Technologies, Inc. are [33, 334].
The SIC codes for Sepax Technologies, Inc. are [38, 382].